J. Ross

发表

Identification and Management of Vascular Risk: Beyond Low Density Lipoprotein Cholesterol

J. Wachs, J. Ross, Margaret A. Manuszak, 2003, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2014, American heart journal.

Educating patients about familial hypercholesterolemia: the role of the cardiovascular nurse.

J. Ross, 2013, The Journal of cardiovascular nursing.

Statins in the Management of Pediatric Dyslipidemia.

J. Ross, 2016, Journal of pediatric nursing.

Long‐term effects of LDL apheresis in patients with severe hypercholesterolemia

D. Rader, B. Sachais, J. Ross, 2005, Journal of clinical apheresis.

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.

Alan S. Brown, A. Gotto, J. Saseen, 2017, Journal of clinical lipidology.

PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers

P. Jellinger, James A. Underberg, P. Toth, 2017, Clinical cardiology.

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Jennifer G. Robinson, S. Daniels, D. Rader, 2011, Journal of clinical lipidology.

Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Jennifer G. Robinson, J. Robinson, A. Goldberg, 2011, Journal of clinical lipidology.

Anaphylactoid‐like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric

D. Siegel, B. Sachais, J. Adamski, 2010, Journal of clinical apheresis.

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

J. Mckenney, S. Grundy, S. Daniels, 2015, Journal of clinical lipidology.

Novel Treatments for Familial Hypercholesterolemia: Pharmacogenetics at Work

J. Ross, J. Marbach, Danielle Duffy, 2014, Pharmacotherapy.

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Jennifer G. Robinson, S. Daniels, D. Rader, 2011, Journal of clinical lipidology.

Primary Prevention of Cardiovascular Disease in Nursing Practice : Focus on Children and Youth

S. Daniels, B. McCrindle, J. Steinberger, 2007 .

Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia.

D. Rader, E. Mohler, E. Meagher, 2001, The American journal of cardiology.

Individualizing Statin Therapy

Michael E. Cobble, J. Ross, 2013 .

The Allied Health Professional’s Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program

J. Ross, 2020, Contemporary Cardiology.

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association.

N L Greengold, D B Smith, J F Toole, 1999, JAMA.

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2014, American heart journal.

Hypertriglyceridemia : Identifying Secondary Causes

C. Bowling, J. Ross, 2022 .